Since its founding, Lifelight has received grants and equity investment from a variety of healthcare and industrial partners, including a $1.5 million award from an NIHR & NHSX AI in Health Award, SBRI Healthcare, and many grants and loans from Innovate UK.
Around 3.5 million dollars was raised on its own over the remaining 14 months of the pandemic. By assessing vital signs using the patient’s own smartphone, Lifelight, which is scientifically regulatory certified, reduces the complexity and cost of the pulse oximeters and blood pressure cuffs. It may be integrated into current healthcare systems and channels, making them more efficient, effective, and scalable. It makes it possible to examine, amend, and reengineer current digital health pathways.
“The firm is committed to bringing to market products that are compliant with clinical regulations and have been validated, making Lifelight a one-of-a-kind solution not only in Europe but across the world.” By staring into a tablet or smartphone’s built-in camera for 40 seconds, Lifelight can monitor blood pressure, breathing rate, pulse, as well as oxygen saturation.